Loading clinical trials...
Loading clinical trials...
Purpose: Study the effect of nepafenac ophthalmic suspension 0.1% to prevent post-operative cystoid macular edema following uncomplicated cataract surgery Participants: Patients having cataract surge...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
NCT04549935 · Patient Preference, Patient Outcomes, and more
NCT05626478 · Corneal Edema, Corneal Defect, and more
NCT00406172 · Cystoid Macular Edema
NCT05474950 · Minocycline, Cystoid Macular Edema
NCT05811182 · Cystoid Macular Edema Following Cataract Surgery, Vitreous Hyperreflective Dots
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions